Ontology highlight
ABSTRACT: Purpose
Using novel Bayesian adaptive designs has great potential to improve the efficiency of early-phase clinical trials. A major barrier for clinical researchers to adopt novel designs is the lack of easy-to-use software. Our purpose is to develop a user-friendly software platform to implement novel clinical trial designs that address various challenges in early-phase dose-finding trials.Methods
We used R Shiny to develop a web-based software platform to facilitate the use of recent novel adaptive designs.Results
We developed a web-based software suite, called Bayesian optimal interval (BOIN) suite, which includes R Shiny applications to handle various clinical settings, including single-agent phase I trials with and without prior information, trials with
SUBMITTER: Zhou Y
PROVIDER: S-EPMC8462603 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature